Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus: pathologic considerations and implications for treatment.

Thomas W Rice1, Joel E Mendelin, John R Goldblum

  • 1Cleveland Clinic Lerner College of Medicine, Section of General Thoracic Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ricet@ccf.org

Seminars in Thoracic and Cardiovascular Surgery
|January 24, 2006
PubMed
Summary

Barrett's esophagus (BE) involves changes in the esophagus due to chronic reflux. Diagnosis requires identifying goblet cells, and differentiating high-grade dysplasia (HGD) from intramucosal cancer (IMC) is crucial for treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Papillary Squamous Intraepithelial Lesion Outside the Uterine Cervix: Clinicopathological Characterization and Immunohistochemical Study.

The American journal of surgical pathology·2026
Same author

Despite simplified diagnostic criteria, intraobserver and interobserver variability remain in the interpretation of colorectal serrated polyps.

Histopathology·2026
Same author

Prospective Identification of Dysplasia in Barrett's Esophagus With Combined Optical Coherence Tomography and Light Scattering Measurements.

Journal of biophotonics·2025
Same author

Durability of cryoballoon ablation for eradication of neoplastic Barrett's esophagus: a multicenter prospective cohort study (with video).

Gastrointestinal endoscopy·2025
Same author

Adjuvant Therapy after Esophagectomy for Esophageal Cancer: Who Needs It?: Multi-institution Worldwide Observational Study.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2024
Same author

Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases.

Histopathology·2024

Area of Science:

  • Gastroenterology
  • Pathology
  • Oncology

Background:

  • Barrett's esophagus (BE) is a condition where the esophageal lining changes due to chronic acid reflux.
  • It is characterized by the presence of goblet cells, confirmed through endoscopic and pathological examination.
  • BE increases the risk of esophageal adenocarcinoma.

Purpose of the Study:

  • To review the diagnostic criteria for Barrett's esophagus.
  • To discuss the challenges in differentiating high-grade dysplasia (HGD) from intramucosal cancer (IMC) in biopsy specimens.
  • To outline current treatment considerations for BE.

Main Methods:

  • Review of endoscopic and pathological diagnostic criteria for BE.
  • Analysis of the histological differentiation between HGD and IMC.

Related Experiment Videos

  • Evaluation of treatment indications and outcomes for BE.

    • Main Results:

    • Goblet cells are the diagnostic hallmark of BE.
    • Distinguishing HGD from IMC on biopsy can be challenging, impacting treatment decisions.
    • Current treatments for BE do not significantly regress the condition or prevent cancer progression.

    Conclusions:

    • Accurate pathological assessment is vital for managing BE.
    • Effective differentiation between HGD and IMC is critical for appropriate patient management.
    • While antireflux surgery is indicated for reflux symptoms, it does not eliminate the risk of cancer in BE patients.